Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546438
APP PUB NO 20120022123A1
SERIAL NO

13162522

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel substituted (thiophenyl-carbonyl)imidazolidinones, methods for their production, their use for the treatment and/or prevention of diseases, as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially retroviral diseases, in humans and/or animals.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYER SCHERING PHARMA AKTIENGESELLSCHAFTMUELLERSTRASSE 170-178 BERLIN D-13342

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Greschat, Susanne Wagenfeld, DE 14 56
Paulsen, Daniela Wuppertal, DE 17 154
Thede, Kai Berlin, DE 56 219
Wildum, Steffen Schwelm, DE 13 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00